Trademark: 77754888
Status Date
Friday, November 12, 2021
Registration Number
3938488
Registration Date
Tuesday, March 29, 2011
Filing Date
Monday, June 8, 2009
Published for Opposition
Tuesday, October 13, 2009
Cancellation Date
Friday, November 12, 2021
42 Medical and scientific research, namely, conducting clinical trials to evaluate the safety and efficacy of anti-allergic treatments
Nov 12, 2021
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Mar 29, 2020
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jun 12, 2016
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jun 11, 2016
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 11, 2016
Case Assigned To Post Registration Paralegal
Apr 1, 2016
Teas Section 8 & 15 Received
Jun 5, 2012
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 5, 2012
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 29, 2011
Registered-Principal Register
Feb 23, 2011
Notice Of Acceptance Of Statement Of Use Mailed
Feb 22, 2011
Law Office Registration Review Completed
Feb 17, 2011
Assigned To Lie
Feb 15, 2011
Allowed Principal Register - Sou Accepted
Jan 21, 2011
Notice Of Approval Of Extension Request Mailed
Jan 20, 2011
Statement Of Use Processing Complete
Dec 23, 2010
Use Amendment Filed
Jan 20, 2011
Extension 2 Granted
Dec 22, 2010
Extension 2 Filed
Jan 20, 2011
Case Assigned To Intent To Use Paralegal
Dec 23, 2010
Teas Statement Of Use Received
Dec 22, 2010
Teas Extension Received
Jul 2, 2010
Notice Of Approval Of Extension Request Mailed
Jun 30, 2010
Extension 1 Granted
Jun 30, 2010
Extension 1 Filed
Jun 30, 2010
Teas Extension Received
Jan 5, 2010
Noa Mailed - Sou Required From Applicant
Oct 13, 2009
Published For Opposition
Sep 23, 2009
Notice Of Publication
Sep 4, 2009
Law Office Publication Review Completed
Sep 4, 2009
Assigned To Lie
Aug 31, 2009
Approved For Pub - Principal Register
Aug 31, 2009
Assigned To Examiner
Jun 11, 2009
New Application Office Supplied Data Entered In Tram
Jun 11, 2009
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
